The American Cancer Society's Web site reports on a non-invasive method of targeting cancer. A Florida-based man with no medical training has invented a machine that could lead to a cure for cancer.
'It gives me goose bumps that there might be a better way to do this and it looks like it's happening,' says John Kanzius, 63, inventor of the machine.
Carbon Nanotubes as Cellular Probes to Study Cell Biochemistry
Carbon nanotubes or nanopipes have proved to be of great use as cellular probes. They can be used to transport liquids to or from cells and inject solutions or drugs directly into the cells.
Advertisement
Kanzius, a former broadcast executive from Pennsylvania always wondered if his background in physics and radio could help in treating the disease from which he suffers himself. Kanzius' device kills cancer cells using radio waves.
Meanwhile scientists in pre-clinical studies have reported that carbon nanotubes embedded in tumors and then heated externally by radio frequency energy can achieve total tumor necrosis.
![CT-guided Radiofrequency Ablation is Effective in Treating Kidney Tumors]( "CT-guided Radiofrequency Ablation is Effective in Treating Kidney Tumors")
A relatively new, minimally invasive treatment was 100 percent successful in eradicating small malignant kidney tumors in a study of more than 100 patients.
Steven A. Curley of the University of Texas M. D. Anderson Cancer Center and colleagues report online in the December issue of Cancer that this approach suggests a potential noninvasive means to treat tumors virtually anywhere in the body.
Though the treatment damaged some healthy tissue next to tumors, investigators found overall results promising. 'There are promising, even exciting, preclinical results in this liver cancer model,' says Dr. Curley. 'Our next step is to look at ways to more precisely target the nanotubes so they attach to, and are taken up by, cancer cells while avoiding normal tissue', he adds.
Radiofrequency destruction of tumors, as currently practiced, has several disadvantages. Needles need to be directly inserted into tumors; incomplete tumor destruction is seen in as many as 40% of cases; nonspecific treatment can damage healthy tissue; and complications of thermal injury could occur in 10% of patients. As a consequence, the therapy is used for only a few malignancies, including liver, kidney, breast, lung, and bone.
Source: Medindia
ANN/M
CT-guided Radiofrequency Ablation is Effective in Treating Kidney Tumors
A relatively new, minimally invasive treatment was 100 percent successful in eradicating small malignant kidney tumors in a study of more than 100 patients.
Advertisement
Steven A. Curley of the University of Texas M. D. Anderson Cancer Center and colleagues report online in the December issue of Cancer that this approach suggests a potential noninvasive means to treat tumors virtually anywhere in the body.
Though the treatment damaged some healthy tissue next to tumors, investigators found overall results promising. 'There are promising, even exciting, preclinical results in this liver cancer model,' says Dr. Curley. 'Our next step is to look at ways to more precisely target the nanotubes so they attach to, and are taken up by, cancer cells while avoiding normal tissue', he adds.
Radiofrequency destruction of tumors, as currently practiced, has several disadvantages. Needles need to be directly inserted into tumors; incomplete tumor destruction is seen in as many as 40% of cases; nonspecific treatment can damage healthy tissue; and complications of thermal injury could occur in 10% of patients. As a consequence, the therapy is used for only a few malignancies, including liver, kidney, breast, lung, and bone.
Source: Medindia
ANN/M
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
The presence of painless swelling in the lymph nodes could potentially indicate lymphatic cancer, say experts.
Women tested at high risk for breast cancer using non-clinical genetic tests overlooking family history may decide to undergo unnecessary breast surgery.
Atezolizumab-bevacizumab drug combination can yield positive outcomes in terms of extended survival and the elimination of liver cancer.
